벡톤디킨슨 (BDX) 주가

벡톤디킨슨(BDX)는 NYSE에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $180.94 (-0.24%), 시가총액 $39.73B, PER (주가수익비율) 25.21, 52주 최저~최고 $143.15 ~ $210.02.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, h

핵심 지표

• 현재가: $180.94 (-0.24%)
• 시가총액: $39.73B
• PER (주가수익비율): 25.21
• 52주 최저~최고: $143.15 ~ $210.02
• 섹터: Healthcare
• 산업: Medical Instruments & Supplies
• 거래소: NYSE

벡톤디킨슨의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

벡톤디킨슨 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3.5882

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 1.71
• 순이익률: 0.05%
• 영업이익률: 0.15%
• 배당수익률: 0.03%

자주 묻는 질문